Novel Shikonin Derivative Suppresses Tumor Growth and Metastasis Intervention of Wnt/β-catenin Pathway
Hongwei Han,Zhongling Wen,Xiaohui Lai,Minkai Yang,Jiangyan Fu,Liangjie Yang,Qingqing Chen,Yudi Ma,Wencai Jie,Changyi Wang,Tongming Yin,Guihua Lu,Xiaoming Wang,Shucun Sun,Quan Zhao,Jinliang Qi,Hongyan Lin,Yonghua Yang
DOI: https://doi.org/10.1016/j.procbio.2023.07.027
IF: 4.885
2023-01-01
Process Biochemistry
Abstract:Colorectal cancer is a common malignancy and the second leading cause of cancer-related death. Emerging evidence suggests that the Wnt/β-catenin pathway has a significant role in cancer development. Shikonin is one of the main bioactive components of the plant, Lithospermum erythrorhizon, which possesses various biological properties. In this study, we identified a shikonin derivative, E5, as a novel suppressor of colorectal carcinoma that acted by inhibiting cell proliferation and migration, and promoting apoptosis. Mechanistically, the drug activated caspase-dependent pathways, negatively regulating the Wnt/β-catenin pathway, and inhibited epithelial–mesenchymal transition. The findings suggest the potential of β-catenin as a molecular target in colon carcinoma and propose E5 as a promising therapeutic strategy for targeting Wnt/β-catenin